1. Agnarsson BA, Vonderheid EC, Kadin ME (1990) Cutaneous T cell lymphoma with suppressor/cyto-toxic (CD8) phenotype: identification of rapidly progressive and chronic subtypes. J Am Acad Dermatol 22:569–577
2. Bauch B, Barraud-Klenowssek M, Burg G, Dummer R (1995) Eindrucksvolle Remission einer Mycosis fungoides im Tumorstadium unter low-dose Interferon-α und Acitretin nach erfolgloser Chemotherapie. Z Hautkr 70:200–203
3. Bekkenk MW, Geelen FA, van Voorst Vader PC, Heule F, Geerts ML, van Vloten WA, Meijer CJ, Willemze R (2000) Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 95:3653–3661
4. Berti E, Tomasini D, Vermeer MH, Meijer CJ, Alessi E, Willemze R (1999) Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior. Am J Pathol 155:483–492
5. Burg G, Hess M, Küng E, Dommann S, Dummer R (1994) Semimalignant („pseudolymphomatous“) cutaneous B-cell lymphomas. Dermatol Clin 12:399–407